Novavax Reports More than 8 Times Jump in Quarterly Revenue, but Losses Widen
(Novavax) Biotech firm Novavax announced $298 million in revenues in the second quarter ending June 30, up from 35.54 million reported in the comparable quarter of 2020. For the six…